LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 10 of 15: Cell count and normalized growth rate inhibition values within biological replicate 3. - Dataset (ID:20247)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MDA-MB-231 | GSK1904529A | 0.12 | uM | LJP6 | 2 | H23 | 72 | hr | 1235 | 3913 | 4277 | 0.9148 | 0.9030 |
MDA-MB-231 | GSK1904529A | 0.12 | uM | LJP6 | 3 | H23 | 72 | hr | 1235 | 3982 | 4583 | 0.8688 | 0.8566 |
MDA-MB-231 | GSK1904529A | 0.37 | uM | LJP6 | 1 | H22 | 72 | hr | 1235 | 4084 | 4355 | 0.9376 | 0.9303 |
MDA-MB-231 | GSK1904529A | 0.37 | uM | LJP6 | 2 | H22 | 72 | hr | 1235 | 4089 | 4277 | 0.9560 | 0.9503 |
MDA-MB-231 | GSK1904529A | 0.37 | uM | LJP6 | 3 | H22 | 72 | hr | 1235 | 4088 | 4583 | 0.8919 | 0.8826 |
MDA-MB-231 | GSK1904529A | 1.11 | uM | LJP6 | 1 | H21 | 72 | hr | 1235 | 3958 | 4355 | 0.9087 | 0.8973 |
MDA-MB-231 | GSK1904529A | 1.11 | uM | LJP6 | 2 | H21 | 72 | hr | 1235 | 3856 | 4277 | 0.9015 | 0.8875 |
MDA-MB-231 | GSK1904529A | 1.11 | uM | LJP6 | 3 | H21 | 72 | hr | 1235 | 4084 | 4583 | 0.8911 | 0.8816 |
MDA-MB-231 | GSK1904529A | 3.33 | uM | LJP6 | 1 | H20 | 72 | hr | 1235 | 4527 | 4355 | 1.0393 | 1.0428 |
MDA-MB-231 | GSK1904529A | 3.33 | uM | LJP6 | 2 | H20 | 72 | hr | 1235 | 4296 | 4277 | 1.0044 | 1.0049 |
MDA-MB-231 | GSK1904529A | 3.33 | uM | LJP6 | 3 | H20 | 72 | hr | 1235 | 4289 | 4583 | 0.9358 | 0.9310 |
MDA-MB-231 | GSK1904529A | 10 | uM | LJP6 | 1 | H19 | 72 | hr | 1235 | 4212 | 4355 | 0.9670 | 0.9634 |
MDA-MB-231 | GSK1904529A | 10 | uM | LJP6 | 2 | H19 | 72 | hr | 1235 | 4261 | 4277 | 0.9962 | 0.9957 |
MDA-MB-231 | GSK1904529A | 10 | uM | LJP6 | 3 | H19 | 72 | hr | 1235 | 4188 | 4583 | 0.9137 | 0.9068 |
MDA-MB-231 | Linsitinib | 0.04 | uM | LJP5 | 1 | O24 | 72 | hr | 1235 | 3867 | 4474 | 0.8642 | 0.8488 |
MDA-MB-231 | Linsitinib | 0.04 | uM | LJP5 | 2 | O24 | 72 | hr | 1235 | 3487 | 4578 | 0.7616 | 0.7315 |
MDA-MB-231 | Linsitinib | 0.04 | uM | LJP5 | 3 | O24 | 72 | hr | 1235 | 3969 | 4929 | 0.8052 | 0.7942 |
MDA-MB-231 | Linsitinib | 0.12 | uM | LJP5 | 1 | O23 | 72 | hr | 1235 | 3792 | 4474 | 0.8474 | 0.8294 |
MDA-MB-231 | Linsitinib | 0.12 | uM | LJP5 | 2 | O23 | 72 | hr | 1235 | 3709 | 4578 | 0.8101 | 0.7890 |
MDA-MB-231 | Linsitinib | 0.12 | uM | LJP5 | 3 | O23 | 72 | hr | 1235 | 4146 | 4929 | 0.8411 | 0.8339 |
MDA-MB-231 | Linsitinib | 0.37 | uM | LJP5 | 1 | O22 | 72 | hr | 1235 | 3520 | 4474 | 0.7866 | 0.7574 |
MDA-MB-231 | Linsitinib | 0.37 | uM | LJP5 | 2 | O22 | 72 | hr | 1235 | 3781 | 4578 | 0.8258 | 0.8073 |
MDA-MB-231 | Linsitinib | 0.37 | uM | LJP5 | 3 | O22 | 72 | hr | 1235 | 4060 | 4929 | 0.8237 | 0.8147 |
MDA-MB-231 | Linsitinib | 1.11 | uM | LJP5 | 1 | O21 | 72 | hr | 1235 | 3576 | 4474 | 0.7992 | 0.7725 |
MDA-MB-231 | Linsitinib | 1.11 | uM | LJP5 | 2 | O21 | 72 | hr | 1235 | 3609 | 4578 | 0.7882 | 0.7633 |